Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199

MLA

Shihui Mao, et al. “Inhibition of CPT1a as a Prognostic Marker Can Synergistically Enhance the Antileukemic Activity of ABT199.” Journal of Translational Medicine, vol. 19, no. 1, Apr. 2021, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12967-021-02848-9.

APA

Shihui Mao, Qing Ling, Jiajia Pan, Fenglin Li, Shujuan Huang, Wenle Ye, Wenwen Wei, Xiangjie Lin, Yu Qian, Yungui Wang, Xin Huang, Jiansong Huang, Jinghan Wang, & Jie Jin. (2021). Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199. Journal of Translational Medicine, 19(1), 1–13. https://doi.org/10.1186/s12967-021-02848-9

Chicago

Shihui Mao, Qing Ling, Jiajia Pan, Fenglin Li, Shujuan Huang, Wenle Ye, Wenwen Wei, et al. 2021. “Inhibition of CPT1a as a Prognostic Marker Can Synergistically Enhance the Antileukemic Activity of ABT199.” Journal of Translational Medicine 19 (1): 1–13. doi:10.1186/s12967-021-02848-9.